5-BROMO-4-CHLORO-6-CYCLOPROPYLPYRIMIDINE, 95%, 25g

2-(3-Chloro-5-fluoro-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

3-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95+%, 1g

3-FLUORO-3-METHYLCYCLOBUTAN-1-AMINE HCL, 95.0%, 1g

2-((Tert-butoxycarbonyl)amino)-3-(4-(trifluoromethoxy)phenyl)propanoic acid, 95%, 500mg

tert-Butyl 7-bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 100g

2,1,3-benzoxadiazole-5-carbaldehyde, 95.0%, 10g

1-Azido-2-methoxyethane (50% solution in Monoglyme), 1g

Methyl 3-hydroxy-3-(4-methoxyphenyl)propanoate, 100mg

Fmoc-(R)-3-Amino-3-(4-chlorophenyl)-propionic acid, 97%, 5g

2,3-Dichlorobenzoyl Chloride>98.0%(GC)(T)25g

2-(2,6-Difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 100g

(1alpha,3alpha,5alpha)-1,3,5-Cyclohexanetricarbonitrile>98.0%(GC)1g